Поисковый запрос: (<.>A=Wilding, J. P.H.$<.>) |
Общее количество найденных документов : 28
Показаны документы с 1 по 20
|
|
1.
| Leong K.S. Acute effects of the angiotensin II antagonist, valsartan on heart rate variability in healthy subjects // Eur. J. Clin. Invest., 1999. Vol. 29, Suppl. 1.-С.56
|
2.
| Additive effects of lactation and food restriction to increase hypothalamic neuropeptide Y mRNA in rats // J. Endocrinol., 1997. Vol. 152, N 3.-С.365-369
|
3.
| Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C // Diabetologia, 2005. Vol. 48, N 12.-С.2641-2649
|
4.
| Amylin does not affect insulin sensitivity in man // Diabet Med., 1993. Vol. 10, N 8 Suppl. N3.-С.21
|
5.
| Amylin does not affect insulin sensitivity in man // Diabet. Med., 1993. Vol. 10, N 8 Suppl. N3.-С.21
|
6.
| Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects // Clin. Endocrinol., 2003. Vol. 59, N 1.-С.75-81
|
7.
| Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: Efficacy and safety over 2 years // Diabetes, Obesity and Metab., 2014. Vol. 16, N 2.-С.124-136
|
8.
| Dexamethasone induced increases in hypothalamic neuropeptide Y-reversal with insulin administration // Diabetologia, 1991. Vol. 34, Suppl. N2.-С.115
|
9.
| Does early malnutrition alter hypothalamic appetite programming? // Diabet. Med., 1994. Vol. 11, Suppl. N2.-С.39
|
10.
| Effect of a cooked meat meal on serum creatinine and estimated glomerular filtation rate in diabetes-related kidney disease objective // Diabetes Care, 2014. Vol. 37, N 2.-С.483-487
|
11.
| Effect of a cooked meat meal on serum creatinine and estimated glomerular filtation rate in diabetes-related kidney disease objective // Diabetes Care, 2014. Vol. 37, N 2.-С.483-487
|
12.
| Effects of glucagon-like peptide 1 (7-36 amide) on insulin secretion and insulin sensitivity in healthy volunteers // Diabet. Med., 1993. Vol. 10, N 8 Suppl. N3.-С.14
|
13.
| Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin. A dose-finding study // Diabetes, Obesity and Metab., 2013. Vol. 15, N 5.-С.403-409
|
14.
| Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin. A dose-finding study // Diabetes, Obesity and Metab., 2013. Vol. 15, N 5.-С.403-409
|
15.
| Wilding J.P.H. Endocrine effects of gastrointestinal tumours // Endocr.-Relat. Cancer, 1997. Vol. 4, N 2.-С.179-189
|
16.
| Wilding J.P.H. Endocrine effects of gastrointestinal tumours // Endocr.-Relat. Cancer, 1997. Vol. 4, N 2.-С.179-189
|
17.
| Wilding J.P.H. Endocrine effects of gastrointestinal tumours // Endocr.-Relat. Cancer, 1997. Vol. 4, N 2.-С.179-189
|
18.
| Wilding J.P.H. Endocrine effects of gastrointestinal tumours // Endocr.-Relat. Cancer, 1997. Vol. 4, N 2.-С.179-189
|
19.
| Rajeev S.P. Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition // Diabetes, Obesity and Metab., 2016. Vol. 18, N 2.-С.125-134
|
20.
| Exposure-response analyses of liraglutide 3.0mg for weight management // Diabetes, Obesity and Metab., 2016. Vol. 18, N 5.-С.491-499
|
&uf('+1W2226#',v2226), ?>
|
|